RxSight, Inc. (NASDAQ:RXST – Get Free Report) Director Robert Keith Warner sold 5,498 shares of the company’s stock in a transaction dated Monday, December 11th. The shares were sold at an average price of $35.08, for a total transaction of $192,869.84. Following the completion of the transaction, the director now owns 23,750 shares in the […]
Wells Fargo & Company upgraded shares of RxSight (NASDAQ:RXST – Free Report) from an equal weight rating to an overweight rating in a research report report published on Wednesday morning, Marketbeat Ratings reports. They currently have $42.00 target price on the stock, up from their prior target price of $31.00. A number of other equities […]
Artisan Partners Limited Partnership trimmed its holdings in RxSight, Inc. (NASDAQ:RXST – Free Report) by 21.5% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 2,078,470 shares of the company’s stock after selling 568,171 shares during the quarter. Artisan Partners Limited Partnership owned 6.12% […]
RxSight, Inc. (NASDAQ:RXST – Get Free Report) shares saw an uptick in trading volume on Wednesday . 202,339 shares traded hands during trading, a decline of 44% from the previous session’s volume of 360,275 shares.The stock last traded at $27.30 and had previously closed at $27.20. Analysts Set New Price Targets Several brokerages have recently […]
RxSight, Inc. (NASDAQ:RXST – Get Free Report) Director Bakker Juliet Tammenoms sold 100,000 shares of the firm’s stock in a transaction dated Tuesday, November 14th. The shares were sold at an average price of $27.13, for a total value of $2,713,000.00. Following the completion of the transaction, the director now owns 894,313 shares in the […]